Covered recipient · General Payments record
CALEB C MAGISTRO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$14,289.97
- Reported across 573 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,346.20 | 165 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,730.00 | 2 |
| Travel and Lodging | $792.19 | 4 |
| Education | $18.09 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $4,003.40 | 20 |
| ViiV Healthcare Company | $767.75 | 41 |
| Gilead Sciences, Inc. | $510.30 | 19 |
| Novo Nordisk AS | $210.64 | 11 |
| ABBVIE INC. | $193.83 | 21 |
| Antares Pharma, Inc. | $143.29 | 9 |
| Lilly USA, LLC | $133.70 | 7 |
| Tris Pharma Inc | $115.66 | 5 |
| PFIZER INC. | $101.78 | 5 |
| EMD Serono, Inc. | $73.76 | 3 |
| Acerta Pharma LLC | $72.67 | 4 |
| Abbott Laboratories | $68.81 | 3 |
| Corium, Inc. | $62.79 | 2 |
| Lundbeck LLC | $58.92 | 3 |
| IDORSIA PHARMACEUTICALS US INC | $40.71 | 2 |
| Bausch Health US, LLC | $40.20 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.80 | 2 |
| Axsome Therapeutics, Inc. | $28.15 | 1 |
| Theratechnologies Inc. | $27.74 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.32 | 1 |
| Vanda Pharmaceuticals Inc. | $24.81 | 1 |
| Exact Sciences Corporation | $24.04 | 1 |
| Hologic Sales and Service, LLC | $23.98 | 1 |
| Noven Therapeutics, LLC | $22.49 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.57 | 1 |
| Napo Pharmaceuticals Inc | $17.71 | 1 |
| Esperion Therapeutics, Inc. | $15.00 | 1 |
| Amgen Inc. | $14.76 | 1 |
| DEXCOM, INC. | $13.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (172)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.